Literature DB >> 9851590

Pharmacological properties of homomeric and heteromeric GluR1o and GluR3o receptors.

B S Nielsen1, T G Banke, A Schousboe, D S Pickering.   

Abstract

Homomeric and heteromeric alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunits GluR1o and GluR3o were expressed in Spodoptera frugiperda (Sf9) insect cells. Membranes containing the recombinant receptors showed a doublet of bands of the expected size (99-109 kDa) after western immunoblotting which was shifted to a single band upon deglycosylation. In (R,S)-[3H]AMPA binding experiments, high expression was seen (Bmax = 0.8-3.8 pmol/mg protein) along with high affinity binding to a single site (Kd, nM+/-S.D.): GluR1o, 32.5+/-2.7; GluR3o, 23.7+/-2.4; GluR1o + GluR3o, 18.1+/-2.9. The pharmacological profiles of these receptors resembled that of native rat brain AMPA receptors: AMPA analogues > L-glutamate > quinoxaline-2,3-diones > kainate. In the Xenopus oocyte expression system we had previously shown that the agonist (R,S)-2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionate (ACPA) exhibited an 11-fold selectivity for GluR3o vs. GluR1o. In this study, it was found that ACPA has 3-fold higher affinity at homomeric GluR3o and heteromeric receptors than at homomeric GluR1o, suggesting that its efficacy and/or desensitisation properties are different at GluR1o vs. GluR3o.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851590     DOI: 10.1016/s0014-2999(98)00668-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Identification of amino acid residues in GluR1 responsible for ligand binding and desensitization.

Authors:  T G Banke; J R Greenwood; J K Christensen; T Liljefors; S F Traynelis; A Schousboe; D S Pickering
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

2.  Discovery of a new class of ionotropic glutamate receptor antagonists by the rational design of (2S,3R)-3-(3-carboxyphenyl)-pyrrolidine-2-carboxylic acid.

Authors:  Ann M Larsen; Raminta Venskutonytė; Elena Antón Valadés; Birgitte Nielsen; Darryl S Pickering; Lennart Bunch
Journal:  ACS Chem Neurosci       Date:  2010-11-12       Impact factor: 4.418

3.  Physiological significance of high- and low-affinity agonist binding to neuronal and recombinant AMPA receptors.

Authors:  Markus Kessler; Erika Suzuki; Kyle Montgomery; Amy C Arai
Journal:  Neurochem Int       Date:  2008-03-08       Impact factor: 3.921

4.  Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site.

Authors:  Trine Kvist; Thomas Bielefeldt Steffensen; Jeremy R Greenwood; Fatemeh Mehrzad Tabrizi; Kasper B Hansen; Michael Gajhede; Darryl S Pickering; Stephen F Traynelis; Jette Sandholm Kastrup; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

5.  Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization.

Authors:  Lina Juknaitė; Yutaro Sugamata; Kazuya Tokiwa; Yuichi Ishikawa; Satoshi Takamizawa; Andrew Eng; Ryuichi Sakai; Darryl S Pickering; Karla Frydenvang; Geoffrey T Swanson; Jette S Kastrup; Masato Oikawa
Journal:  J Med Chem       Date:  2013-03-13       Impact factor: 7.446

6.  Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine.

Authors:  Karla Frydenvang; L Leanne Lash; Peter Naur; Pekka A Postila; Darryl S Pickering; Caleb M Smith; Michael Gajhede; Makoto Sasaki; Ryuichi Sakai; Olli T Pentikaïnen; Geoffrey T Swanson; Jette S Kastrup
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.